project id: TCGA-HNSC; case submitter id: TCGA-KU-A66S; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 2.23; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.19; rna integrity number: 8.9; age at index: 69; days to birth: -25454; days to death: 406; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1943; age at diagnosis: 25454; ajcc clinical m: MX; ajcc clinical n: N1; ajcc clinical stage: Stage III; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 224.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: No; cigarettes per day: 2.73972602739726; pack years smoked: 50.0; is ffpe: false; composition: Not Reported; days to collection: 150; days to sample procurement: 0; initial weight: 600.0; portion submitter id: TCGA-KU-A66S-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0;